Related references
Note: Only part of the references are listed.Location, Location, Location: Macrophage Positioning within Tumors Determines Pro- or Antitumor Activity
Lee B. Rivera et al.
CANCER CELL (2013)
Phosphoinositide 3-Kinase δ Gene Mutation Predisposes to Respiratory Infection and Airway Damage
Ivan Angulo et al.
SCIENCE (2013)
Treatment Option(s) for Pulmonary Lymphangioleiomyomatosis: Progress and Current Challenges
Vera P. Krymskaya
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2012)
Lymphangioleiomyomatosis - a wolf in sheep's clothing
Elizabeth P. Henske et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Prevention of Alveolar Destruction and Airspace Enlargement in a Mouse Model of Pulmonary Lymphangioleiomyomatosis ( LAM)
Elena A. Goncharova et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
mTORC2 Is Required for Proliferation and Survival of TSC2-Null Cells
Elena A. Goncharova et al.
MOLECULAR AND CELLULAR BIOLOGY (2011)
Regulation of tumor invasion by interstitial fluid flow
Adrian C. Shieh et al.
PHYSICAL BIOLOGY (2011)
mTORC2 Regulates Neutrophil Chemotaxis in a cAMP- and RhoA-Dependent Fashion
Lunhua Liu et al.
DEVELOPMENTAL CELL (2010)
PI3K/mTORC1 activation in hamartoma syndromes Therapeutic prospects
Vera P. Krymskaya et al.
CELL CYCLE (2009)
Pulmonary lymphangioleiomyomatosis (LAM): Progress and current challenges
Elena A. Goncharova et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
Lymphatic drainage function and its immunological implications: From dendritic cell homing to vaccine design
Melody A. Swartz et al.
SEMINARS IN IMMUNOLOGY (2008)
PDGFRs are critical for PI3K/Akt activation and negatively regulated by mTOR
Hongbing Zhang et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Molecular pathogenesis of lymphangioleiomyomatosis - Lessons learned from orphans
Stephen C. Juvet et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2007)
Classical transient receptor potential channel 6 (TRPC6) is essential for hypoxic pulmonary vasoconstriction and alveolar gas exchange
Norbert Weissmann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The tuberous sclerosis complex
Peter B. Crino et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Activity of TSC2 is inhibited by AKT-mediated phosphorylation and membrane partitioning
SL Cai et al.
JOURNAL OF CELL BIOLOGY (2006)
Modulation of cell migration and invasiveness by tumor suppressor TSC2 in lymphangioleiomyomatosis
EA Goncharova et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2006)
Lymphangiogenesis-mediated shedding of LAM cell clusters as a mechanism for dissemination in lymphangioleiomyomatosis
T Kumasaka et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2005)
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
DD Sarbassov et al.
SCIENCE (2005)
TSC2 modulates actin cytoskeleton and focal adhesion through TSC1-binding domain and the Rac1 GTPase
E Goncharova et al.
JOURNAL OF CELL BIOLOGY (2004)
Molecular and genetic analysis of disseminated neoplastic cells in lymphangioleiomyomatosis
DM Crooks et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton
DD Sarbassov et al.
CURRENT BIOLOGY (2004)
Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive
E Jacinto et al.
NATURE CELL BIOLOGY (2004)
TSC2 mediates cellular energy response to control cell growth and survival
K Inoki et al.
CELL (2003)
Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling
K Inoki et al.
GENES & DEVELOPMENT (2003)
Cyclic AMP-mobilizing agents and glucocorticoids modulate human smooth muscle cell migration
EA Goncharova et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2003)
Recurrent lymphangiomyomatosis after transplantation - Genetic analyses reveal a metastatic mechanism
M Karbowniczek et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
Tuberin regulates p70 S6 kinase activation and ribosomal protein S6 phosphorylation -: A role for the TSC2 tumor suppressor gene in pulmonary lymphangioleiomyomatosis (LAM)
EA Goncharova et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Activation of p38 MAP-kinase and caldesmon phosphorylation are essential for urokinase-induced human smooth muscle cell migration
EA Goncharova et al.
BIOLOGICAL CHEMISTRY (2002)
Mutation analysis of the TSC1 and TSC2 genes in Japanese patients with pulmonary lymphangioleiomyomatosis
T Sato et al.
JOURNAL OF HUMAN GENETICS (2002)
TSC2 missense mutations inhibit tuberin phosphorylation and prevent formation of the tuberin-hamartin complex
M Nellist et al.
HUMAN MOLECULAR GENETICS (2001)
Chromosome 16 loss of heterozygosity in tuberous sclerosis and sporadic lymphangiomyomatosis
J Yu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)
Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs
SL Dabora et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)
TOR, a central controller of cell growth
T Schmelzle et al.
CELL (2000)
The TSC1 tumour suppressor hamartin regulates cell adhesion through ERM proteins and the GTPase Rho
RF Lamb et al.
NATURE CELL BIOLOGY (2000)
Share Paper
